| Style | Citing Format |
|---|---|
| MLA | Ajdary N, et al.. "Development and Characterization of Colloidally Stable Dendrimer-Botox Conjugates for Targeted Muscle Delivery and Radiolabeled Imaging." Pharmaceutical Sciences, vol. 32, no. 2, 2026, pp. 201-218. |
| APA | Ajdary N, Davoudi M, Mehrizi T Z, Ardestani M S, Marnani H N, Shahmabadi H E (2026). Development and Characterization of Colloidally Stable Dendrimer-Botox Conjugates for Targeted Muscle Delivery and Radiolabeled Imaging. Pharmaceutical Sciences, 32(2), 201-218. |
| Chicago | Ajdary N, Davoudi M, Mehrizi T Z, Ardestani M S, Marnani H N, Shahmabadi H E. "Development and Characterization of Colloidally Stable Dendrimer-Botox Conjugates for Targeted Muscle Delivery and Radiolabeled Imaging." Pharmaceutical Sciences 32, no. 2 (2026): 201-218. |
| Harvard | Ajdary N et al. (2026) 'Development and Characterization of Colloidally Stable Dendrimer-Botox Conjugates for Targeted Muscle Delivery and Radiolabeled Imaging', Pharmaceutical Sciences, 32(2), pp. 201-218. |
| Vancouver | Ajdary N, Davoudi M, Mehrizi T Z, Ardestani M S, Marnani H N, Shahmabadi H E. Development and Characterization of Colloidally Stable Dendrimer-Botox Conjugates for Targeted Muscle Delivery and Radiolabeled Imaging. Pharmaceutical Sciences. 2026;32(2):201-218. |
| BibTex | @article{ author = {Ajdary N and Davoudi M and Mehrizi T Z and Ardestani M S and Marnani H N and Shahmabadi H E}, title = {Development and Characterization of Colloidally Stable Dendrimer-Botox Conjugates for Targeted Muscle Delivery and Radiolabeled Imaging}, journal = {Pharmaceutical Sciences}, volume = {32}, number = {2}, pages = {201-218}, year = {2026} } |
| RIS | TY - JOUR AU - Ajdary N AU - Davoudi M AU - Mehrizi T Z AU - Ardestani M S AU - Marnani H N AU - Shahmabadi H E TI - Development and Characterization of Colloidally Stable Dendrimer-Botox Conjugates for Targeted Muscle Delivery and Radiolabeled Imaging JO - Pharmaceutical Sciences VL - 32 IS - 2 SP - 201 EP - 218 PY - 2026 ER - |